AG
EW icon

Ascent Group’s Edwards Lifesciences EW Stock Holding History

Ascent Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$403K Buy
5,031
+2,003
+66% +$165K 0.01% 548
2025
Q4 		$258K Sell
3,028
-156
-5% -$12.8K 0.01% 655
2025
Q3 		$248K Sell
3,184
-15
-0.5% -$1.17K 0.01% 655
2025
Q2 		$250K Buy
+3,199
New +$239K 0.01% 628
2024
Q3 		– Sell
-2,719
Closed -$251K – 531
2024
Q2 		$251K Sell
2,719
-1,364
-33% -$121K 0.02% 455
2024
Q1 		$390K Sell
4,083
-1,745
-30% -$147K 0.03% 390
2023
Q4 		$508K Sell
5,828
-252
-4% -$17.5K 0.05% 344
2023
Q3 		$393K Sell
6,080
-10,884
-64% -$875K 0.04% 350
2023
Q2 		$1.33M Sell
16,964
-5,859
-26% -$509K 0.15% 195
2023
Q1 		$1.89M Sell
22,823
-433
-2% -$34K 0.2% 151
2022
Q4 		$1.74M Buy
23,256
+356
+2% +$27.4K 0.2% 151
2022
Q3 		$1.66M Buy
22,900
+394
+2% +$37.9K 0.2% 146
2022
Q2 		$2.26M Sell
22,506
-35
-0.2% -$3.62K 0.27% 111
2022
Q1 		$2.65M Sell
22,541
-6,697
-23% -$751K 0.31% 108
2021
Q4 		$3.29M Buy
+29,238
New +$3.41M 0.42% 70

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ascent Group's EW Position: Q1 2026 in Review

Ascent Group increased its Edwards Lifesciences (EW) stake by 66% in Q1 2026, buying an estimated $165K and bringing the position to 5,031 shares worth $403K. The position accounts for 0.01% of the portfolio, ranked #548.

Ascent Group first reported a position in EW in Q4 2021 and has held it in 15 quarters since. The position peaked at $3.29M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Ascent Group held 5,031 shares of Edwards Lifesciences worth $403K as of Q1 2026.
  • Ascent Group bought 2,003 Edwards Lifesciences shares in Q1 2026, an estimated $165K.
  • Edwards Lifesciences made up 0.01% of Ascent Group's portfolio in Q1 2026, its #548 holding.
  • Ascent Group first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 15 quarters since.
  • Ascent Group's Edwards Lifesciences position peaked at $3.29M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.